Markers of cochlear inflammation using MRI

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 1, 2014, Pages 150-161

  Floc'H, Johann Le ^a   Tan, Winston ^a   Telang, Ravindra S ^a   Vlajkovic, Srdjan M ^a   Nuttall, Alfred ^b   Rooney, William D ^c   Pontré, Beau ^a   Thorne, Peter R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

blood labyrinth barrier; cochlear inflammation; lipopolysaccharide; MRI; ultrasmall superparamagnetic iron oxide; vascular permeability

Indexed keywords

FERRIC FERROCYANIDE; GADOLINIUM PENTETATE; LIPOPOLYSACCHARIDE; MARKER; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; COCHLEAR INFLAMMATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GUINEA PIG; INNER EAR DISEASE; MACROPHAGE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PILOT STUDY; PRIORITY JOURNAL;

BLOOD-LABYRINTH BARRIER; COCHLEAR INFLAMMATION; LIPOPOLYSACCHARIDE; MRI; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VASCULAR PERMEABILITY;

ANIMALS; COCHLEA; COCHLEAR DISEASES; CONTRAST MEDIA; FEMALE; FERRIC COMPOUNDS; FERROCYANIDES; GADOLINIUM; GUINEA PIGS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; PERMEABILITY; TIME FACTORS;

EID: 84890531630     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24144     Document Type: Article

References (52)

1. Listen hear! The economic impact and cost of hearing loss in Australia. New South Wales: Access Economics Pty Ltd; 2006. 91 p.
2. Thorne PR, Ameratunga S, Stewart J, et al. Epidemiology of noise-induced hearing loss in New Zealand. NZ Med J 2008; 121: 33-44.
3. Migirov L, Kronenberg J, Volkov A,. Local tissue response to cochlear implant device housings. Otol Neurotol 2011; 32: 55-57.
4. Cureoglu S, Schachern PA, Rinaldo A, Tsuprun V, Ferlito A, Paparella MM,. Round window membrane and labyrinthine pathological changes: an overview. Acta Otolaryngol 2005; 125: 9-15.
5. Tornabene SV, Sato K, Pham L, Billings P, Keithley EM,. Immune cell recruitment following acoustic trauma. Hear Res 2006; 222: 115-124.
6. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF,. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007; 117: 3-15.
7. Mark AS, Fitzgerald D,. Segmental enhancement of the cochlea on contrast-enhanced MR-correlation with the frequency of hearing-loss and possible sign of perilymphatic fistula and autoimmune labyrinthitis. Am J Neuroradiol 1993; 14: 991-996.
8. Sone M, Mizuno T, Naganawa S, Nakashima T,. Imaging analysis in cases with inflammation-induced sensorineural hearing loss. Acta Otolaryngologica 2009; 129: 239-243.
9. Naganawa S, Ishihara S, Iwano S, Kawai H, Sone M, Nakashima T,. Estimation of gadolinium-induced T1-shortening with measurement of simple signal intensity ratio between the cochlea and brain parenchyma on 3D-FLAIR: correlation with T1 measurement by TI scout sequence. Magn Reson Med Sci 2010; 9: 17-22.
10. Naganawa S, Nakashima T,. Cutting edge of inner ear MRI. Acta Otolaryngol 2009; 129: 15-21.
11. Zou J, Poe D, Bjelke B, Pyykko I,. Visualization of inner ear disorders with MRI in vivo: from animal models to human application. Acta Otolaryngol 2009; 129: 22-31.
12. Counter SA, Bjelke B, Borg E, Klason T, Chen ZG, Duan ML,. Magnetic resonance imaging of the membranous labyrinth during in vivo gadolinium (Gd-DTPA-BMA) uptake in the normal and lesioned cochlea. Neuroreport 2000; 11: 3979-3983.
13. Zou J, Pyykko I, Bretlau P, Klason T, Bjelke B,. In vivo visualization of endolymphatic hydrops in guinea-pigs: magnetic resonance imaging evaluation at 4.7 tesla. Ann Otol Rhinol Laryngol 2003; 112: 1059-1065.
14. Pyykko I, Zou J, Poe D, Nakashima T, Naganawa S,. Magnetic resonance imaging of the inner ear in Meniere's disease. Otolaryngol Clin North Am 2010; 43: 1059-1080.
15. Seltzer S, Mark AS,. Contrast enhancement of the labyrinth on MR scans in patients with sudden hearing loss and vertigo: evidence of labyrinthine disease. AJNR Am J Neuroradiol 1991; 12: 13-16.
16. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232.
17. Buckley DL,. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002; 47: 601-606.
18. Landis CS, Li X, Telang FW, et al. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med 2000; 44: 563-574.
19. Li X, Rooney WD, Springer CS,. A unified magnetic resonance imaging pharmacokinetic theory: intravascular and extracellular contrast reagents. Magn Reson Med 2005; 54: 1351-1359.
20. Donahue KM, Weisskoff RM, Chesler DA, et al. Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange. Magn Reson Med 1996; 36: 858-867.
21. Cao Y, Brown SL, Knight RA, Fenstermacher JD, Ewing JR,. Effect of intravascular-to-extravascular water exchange on the determination of blood-to-tissue transfer constant by magnetic resonance imaging. Magn Reson Med 2005; 53: 282-293.
22. Kershaw LE, Cheng HLM,. Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model. Magn Reson Med 2010; 64: 1772-1780.
23. Sourbron SP, Buckley DL,. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011; 66: 735-745.
24. Bartos M, Keunen O, JiËrik R, Bjerkvig R, Taxt T,. Perfusion analysis of dynamic contrast enhanced magnetic resonance images using a fully continuous tissue homogeneity model with mean transit. Anal Biomed Sign Images 2010; 20: 269-274.
25. Bulte JW, Kraitchman DL,. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17: 484-499.
26. Dousset V, Delalande C, Ballarino L, et al. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 1999; 41: 329-333.
27. Corot C, Robert P, Idee JM, Port M,. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006; 58: 1471-1504.
28. Weinstein JS, Varallyay CG, Dosa E, et al. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 2010; 30: 15-35.
29. Zou J, Zhang W, Poe D, et al. MRI manifestation of novel superparamagnetic iron oxide nanoparticles in the rat inner ear. Nanomedicine 2010; 5: 739-754.
30. Takumida M, Anniko M, Popa R,. Possible involvement of free radicals in lipopolysaccharide-induced labyrinthitis in the guinea-pig: a morphological and functional investigation. ORL J Otorhinolaryngology Relat Spec 1998; 60: 246-253.
31. Fram EK, Herfkens RJ, Johnson GA, et al. Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging 1987; 5: 201-208.
32. Buckley D, Parker G,. Measuring contrast agent concentration in T1-weighted dynamic contrast-enhanced MRI. Dyn Contrast-Enhanced Magn Reson Imaging Oncol 2005; 69-79.
33. Swan EEL, Mescher MJ, Sewell WF, Tao SL, Borenstein JT,. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008; 60: 1583-1599.
34. Rooney WD, Johnson G, Li X, et al. Magnetic field and tissue dependencies of human brain longitudinal 1H2O Relaxation in Vivo. Magn Reson Med 2007; 57: 308-318.
35. Geraldes CF, Urbano AM, Alpoim MC, et al. Preparation, physico-chemical characterization, and relaxometry studies of various gadolinium(III)-DTPA- bis(amide) derivatives as potential magnetic resonance contrast agents. Magn Reson Imaging 1995; 13: 401-420.
36. Pearse AGE,. Histochemistry. Boston: Little, Brown and Co; 1961. 998 p.
37. Zou J, Zhang W, Poe D, Zhang Y, Ramadan UA, Pyykko I,. Differential passage of gadolinium through the mouse inner ear barriers evaluated with 4.7T MRI. Hear Res 2009; 259: 36-43.
38. Faranesh AZ, Kraitchman DL, McVeigh ER,. Measurement of kinetic parameters in skeletal muscle by magnetic resonance imaging with an intravascular agent. Magn Reson Med 2006; 55: 1114-1123.
39. Jaspers K, Leiner T, Dijkstra P, et al. Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: effect of contrast agent size. Med Phys 2010; 37: 5746-5755.
40. Floris S, Blezer ELA, Schreibelt G, et al. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis-A quantitative MRI study. Brain 2004; 127: 616-627.
41. Hodgson RJ, Connolly S, Barnes T, Eyes B, Campbell RS, Moots R,. Pharmacokinetic modeling of dynamic contrast-enhanced MRI of the hand and wrist in rheumatoid arthritis and the response to anti-tumor necrosis factor-alpha therapy. Magn Reson Med 2007; 58: 482-489.
42. Li X, Huang W, Morris EA, et al. Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRI. Proc Natl Acad Sci U S A 2008; 105: 17937-17942.
43. Alper CM, Tabari R, Seroky JT, Doyle WJ,. Magnetic resonance imaging of the development of otitis media with effusion caused by functional obstruction of the eustachian tube. Ann Otol Rhinol Laryngol 1997; 106: 422-431.
44. Chan KH, Swarts JD, Tan L,. Middle ear mucosal inflammation: an in vivo model. Laryngoscope 1994; 104: 970-980.
45. Metrikin DC, Wilson CA, Berkowitz BA, Lam MK, Wood GK, Peshock RM,. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis. Invest Ophthalmol Vis Sci 1995; 36: 1361-1370.
46. Sironi L, Guerrini U, Tremoli E, et al. Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach. J Neurosci Res 2004; 78: 115-122.
47. Tigani B, Cannet C, Karmouty-Quintana H, et al. Lung inflammation and vascular remodeling after repeated allergen challenge detected noninvasively by MRI. Am J Physiol Lung Cell Mol Physiol 2007; 292: L644-L653.
48. Watanabe K, Jinnouchi K, Hess A, et al. Detection of apoptotic change in the lipopolysaccharide (LPS)-treated cochlea of guinea pigs. Hear Res 2001; 158: 116-122.
49. Levy M, Luciani N, Alloyeau D, et al. Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials 2011; 32: 3988-3999.
50. Dai M, Yang Y, Omelchenko I, et al. Bone marrow cell recruitment mediated by inducible nitric oxide synthase/stromal cell-derived factor-1alpha signaling repairs the acoustically damaged cochlear blood-labyrinth barrier. Am J Pathol 2010; 177: 3089-3099.
51. Shi X,. Resident macrophages in the cochlear blood-labyrinth barrier and their renewal via migration of bone-marrow-derived cells. Cell Tissue Res 2010; 342: 21-30.
52. Davoust N, Pialat JB, Moucharaffie S, et al. MR-tracking of in vivo magnetically labeled macrophages detects remote inflammation in focal ischemia of the mouse brain. In: Proceedings of the 8th International Conference of Neuroimmunology, Nagoya, 2006. (abstract 178:250).